Report cover image

U.S Pharmaceutical Market Growth, Size, Trends Analysis - By Molecule, By Product, By Type, By Route of Administration, By Disease, By Age Group, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Jul 02, 2025
Length 231 Pages
SKU # SPER20295387

Description

U.S Pharmaceutical Market Introduction and Overview

According to SPER market research, ‘U.S Pharmaceutical Market Size- By Molecule, By Product, By Type, By Route of Administration, By Disease, By Age Group, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the U.S Pharmaceutical Market is predicted to reach 1138.67 billion by 2034 with a CAGR of 6.01%.

Pharmaceuticals are substances used in the diagnosis, treatment, prevention, and management of diseases and medical conditions. This field encompasses a wide range of products, including prescription drugs, over-the-counter medications, biologics, and vaccines. The pharmaceutical industry plays a critical role in modern healthcare by developing and delivering innovative therapies that improve quality of life and extend life expectancy.

Restraints:
Despite being the largest pharmaceutical market in the world, the US faces a number of significant obstacles. The increasing expense of medication development and pricing pressures, which frequently result in political and public scrutiny, is one significant problem. The introduction of innovative treatments may be delayed by complex regulatory procedures and protracted approval procedures. Additionally, branded pharma producers are under pressure to develop quickly due to the increasing competition from generics and biosimilars.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered
By Molecule, By Product, By Type, By Route of Administration, By Disease, By Age Group, By Distribution Channel

Regions covered
Northeast, Midwest, West, South

Companies Covered

AbbVie Inc, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, GSK plc, Johnson & Johnson Services, Inc, Merck & Co., Inc, Novartis AG, Pfizer Inc, Sanofi, Takeda Pharmaceutical Company Limited.

U.S Pharmaceutical Market Segmentation:

By Molecule: Based on the Molecule, U.S Pharmaceutical Market is segmented as; Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules).

By Product:
Based on the Product, U.S Pharmaceutical Market is segmented as; Branded, Generic.

By Type: Based on the Type, U.S Pharmaceutical Market is segmented as; Prescription, OTC.

By Route of Administration: Based on the Route of Administration, U.S Pharmaceutical Market is Segmented as; Oral, Topical, Parenteral, Inhalation, Others.

By Disease: Based on the Disease, U.S Pharmaceutical Market is Segmented as; Cancer, Diabetes, Obesity, Renal Diseases, Liver Condition, Others.

By Age Group: Based on the Age Group, U.S Pharmaceutical Market is Segmented as; Children & Adolescents, Adults, Geriatric.

By Distribution Channel: Based on the Distribution Channel, U.S Pharmaceutical Market is Segmented as; Hospital Pharmacy, Retail Pharmacy, Others.

By Region:
This research also includes data Northeast, Midwest, West, South.

Table of Contents

231 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. U.S Pharmaceutical Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in U.S Pharmaceutical Market
7. U.S Pharmaceutical Market, By Molecule 2021-2034 (USD Million)
7.1. Biologics & Biosimilars (Large Molecules)
7.1.1. Monoclonal Antibodies
7.1.2. Vaccines
7.1.3. Cell & Gene Therapy
7.1.4. Others
7.2. Conventional Drugs (Small Molecules)
8. U.S Pharmaceutical Market, By Product 2021-2034 (USD Million)
8.1. Branded
8.2. Generic
9. U.S Pharmaceutical Market, By Type 2021-2034 (USD Million)
9.1. Prescription
9.2. OTC
10. U.S Pharmaceutical Market, By Route of Administration 2021-2034 (USD Million)
10.1. Oral
10.1.1. Tablet Capsule
10.1.2. Suspensions
10.1.3. Other
10.2. Topical
10.3. Parenteral
10.3.1. Intravenous
10.3.2. Intramuscular
10.4. Inhalations
10.5. Others
11. U.S Pharmaceutical Market, By Disease 2021-2034 (USD Million)
11.1. Cancer
11.2. Diabetes
11.3. Obesity
11.4. Renal Diseases
11.5. Liver Conditions
11.6. Others
12. U.S Pharmaceutical Market, By Age Group 2021-2034 (USD Million)
12.1. Children & Adolescents
12.2. Adults
12.3. Geriatric
13. U.S Pharmaceutical Market, By Distribution Channel 2021-2034 (USD Million)
13.1. Hospital Pharmacy
13.2. Retail Pharmacy
13.3. Others
14. U.S Pharmaceutical Market, 2021-2034 (USD Million)
14.1. U.S Pharmaceutical Market Size and Market Share
15. U.S Pharmaceutical Market, By Region, 2021-2034 (USD Million)
15.1. Northeast
15.2. Midwest
15.3. West
15.4. South
16. Company Profile
16.1. AbbVie Inc
16.1.1. Company details
16.1.2. Financial outlook
16.1.3. Product summary
16.1.4. Recent developments
16.2. Bristol-Myers Squibb Company
16.2.1. Company details
16.2.2. Financial outlook
16.2.3. Product summary
16.2.4. Recent developments
16.3. F. Hoffmann-La Roche Ltd
16.3.1. Company details
16.3.2. Financial outlook
16.3.3. Product summary
16.3.4. Recent developments
16.4. GSK plc
16.4.1. Company details
16.4.2. Financial outlook
16.4.3. Product summary
16.4.4. Recent developments
16.5. Johnson & Johnson Services, Inc
16.5.1. Company details
16.5.2. Financial outlook
16.5.3. Product summary
16.5.4. Recent developments
16.6. Merck & Co., Inc
16.6.1. Company details
16.6.2. Financial outlook
16.6.3. Product summary
16.6.4. Recent developments
16.7. Novartis AG
16.7.1. Company details
16.7.2. Financial outlook
16.7.3. Product summary
16.7.4. Recent developments
16.8. Pfizer Inc
16.8.1. Company details
16.8.2. Financial outlook
16.8.3. Product summary
16.8.4. Recent developments
16.9. Sanofi
16.9.1. Company details
16.9.2. Financial outlook
16.9.3. Product summary
16.9.4. Recent developments
16.10. Takeda Pharmaceutical Company Limited
16.10.1. Company details
16.10.2. Financial outlook
16.10.3. Product summary
16.10.4. Recent developments
16.11. Others
17. Conclusion
18. List of Abbreviations
19. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us